Safety assessment of nanoparamagnetic contrast agents with different coatings for molecular MRI

• Autorzy: Azizian G , Riyahi-Alam N , Haghgoo S , Saffari M , Zohdiaghdam R , Gorji E
• Języki publikacji: EN

Abstrakty

EN

Despite the wide application of gadolinium as a contrast agent for magnetic resonance imaging (MRI), there is a serious lack of information on its toxicity. Gadolinium and gadolinium oxide (Gd-oxide) are used as contrast agents for magnetic resonance imaging (MRI). There are methods for reducing toxicity of these materials, such as core nanoparticles coating or conjugating. Therefore, for toxicity evaluation, we compared the viability of commercial contrast agents in MRI (Gd-DTPA) and three nanoparticles with the same core Gd2O3 and small particulate gadolinium oxide or SPGO (< 40 nm) but different coatings of diethyleneglycol (DEG) as Gd2O3-DEG and methoxy polyethylene glycol-silane (mPEG-silane: 550 and 2000 Dalton) as SPGO-mPEG-silane550 and SPGO-mPEG-silane2000, respectively, in the SK-MEL3 cell line, by light microscopy, MTT assay using 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide, and the LDH assay detecting lactate dehydrogenase activity. The viability values were not statistically different between the three nanoparticles and Gd-DTPA. The MTT and LDH assay results showed that Gd2O3-DEG nanoparticles were more toxic than Gd-DTPA and other nanoparticles. Also, SPGO-mPEG-silane2000 was more biocompatible than other nanoparticles. The obtained results did not show any significant increase in cytotoxicity of the nanoparticles and Gd-DTPA, neither dose-dependent nor time-dependent. Therefore, DEG and PEG, due to their considerable properties and irregular sizes (different molecular weights), were selected as the useful surface covering materials of nanomagnetic particles that could reveal noticeable relaxivity and biocompatibility characteristics.

Słowa kluczowe

EN

gadolinium oxide; diethylene glycol; polyethyleneglycol; toxicity

• Wydawca: De Gruyter
• Czasopismo: Materials Science Poland
• Rocznik: 2013
• Tom: Vol. 31, No. 2
• Strony: 158--164
• Opis fizyczny: Bibliogr. 25 poz., rys., tab.

Twórcy

autor

Azizian G

• Medical Physics & Biomedical Engineering Department, School of Medicine, Tehran University of Medical Sciences (TUMS), Keshavaz blvd., 16 Azar St., Tehran 14145, Iran
• Medical Physics Department, School of Medicine, Hamadan University of Medical Sciences, Madieh St., Hamadan 6517838736, Iran
• Medical Physics & Biomedical Engineering Department, School of Medicine, Tehran University of Medical Sciences (TUMS), Keshavaz blvd., 16 Azar St., Tehran 14145, Iran

autor

Riyahi-Alam N

• Medical Physics & Biomedical Engineering Department, School of Medicine, Tehran University of Medical Sciences (TUMS), Keshavaz blvd., 16 Azar St., Tehran 14145, Iran

autor

Haghgoo S

• Pharmaceutical Department, Food & Drug Laboratory Research Center, Food & Drug Organization (FDO) Ministry of Health, Imam St., Valiasre Cross, Tehran 1113615911, Iran

autor

Saffari M

• Medical Genetics Department, School of Medicine, Tehran University of Medical Sciences (TUMS), Keshavaz blvd., 16 Azar St., Tehran 14145, Iran

autor

Zohdiaghdam R

• Medical Physics & Biomedical Engineering Department, School of Medicine, Tehran University of Medical Sciences (TUMS), Keshavaz blvd., 16 Azar St., Tehran 14145, Iran

autor

Gorji E

• Pharmaceutical Department, Food & Drug Laboratory Research Center, Food & Drug Organization (FDO) Ministry of Health, Imam St., Valiasre Cross, Tehran 1113615911, Iran

Bibliografia

• [1] BOPP S.K., LETTIERI T., BMC Pharmacology, 8 (2008), 8.
• [2] ROCO M., Curr. Opin. Biotechnol., 14 (2003), 337.
• [3] AI J. et al., Int. J. Nanomedicine, 6 (2011), 1117.
• [4] LOBNER D., J. Neurosci. Methods, 96 (2000), 147.
• [5] HUSSAIN S.M., HESS K. L., GEARHART J. M., GEISS K. T., SCHLAGER J. J., Toxicol. in Vitro., 19 (2005), 975.
• [6] MOGHIMI S.M., HUNTER A.C., MURRAY J.C., Pharmacol. Rev., 53 (2001), 283.
• [7] OBERDORSTER G., OBERDORSTER E., OBERDORSTER J., Environ. Health Perspect. 113 (2005), 823.
• [8] LANONE S. et al., Part Fibre Toxicol., 6 (2009), 14.
• [9] POHJALA L., TAMMELA P., SAMANTA S.K., YLI-KAUHALUOMA J., VUORELA P., Anal. Biochem., 362 (2007), 221.
• [10] PANKHURST Q., B.T.Tech. J., 24 (2006), 33.
• [11] SODERLIND F., PEDERSEN H., PETORAL R.M.JR., KALL P.O., UVDAL K., J. Colloid. Interface Sci., 228 (2005), 140.
• [12] ENGSTROM M. et al., MAGMA., 19 (2006), 180.
• [13] RIYAHI-ALAM N., BEHROUZKIA Z., SEIFALIAN A., HAGHGOO JAHROMI S., Biol. Trace. Elem. Res., 137 (2010), 324.
• [14] KLASSON A. et al., Contrast Media. Mol. Imaging., 3 (2008), 106.
• [15] FAUCHER L., GOSSUIN Y., HOCQ A. AND FORTIN M.A., Nanotechnology, 22 (2011), 295103
• [16] KAMALY N. et al., Mol. Imaging Biol., 12 (2010), 361.
• [17] DORION A.L., CHU K., ALI A., BRANNON-PEPPAS L., Proc. Natl. Acad. Sci. U S A. 105 (2008), 17232.
• [18] SCHIPPER M.L. et al., Small, 5 (2009), 126.
• [19] OYEWUMIA M.O., YOKEL R. A., JAY M., COAKLEY T., MUMPER R.J., J. Controll. Release, 95 (2004), 613.
• [20] NELSON J.A.., BENNETT L.H., WAGNER M.J., J. Am. Chem. Soc., 124 (2002), 333.
• [21] FORTIN M.A. et al., Nanotechnology, 18 (2007), 395501.
• [22] MOSMANN T., Immunol. Methods, 65 (1983), 55.
• [23] DERFUS A., CHAN W., BHATIA S., Nano Lett., 4 (2004), 11.
• [24] BRAYDICH-STOLLE L., HUSSAIN S., SCHLAGER J.J., HOFMANN M.C., Toxicol. Sci., 88 (2005), 412.
• [25] YEDJOU C.G., MOORE P., TCHOUNWOU P. B., Int. J. Environ. Res. Public Health., 3 (2006), 136.